Children have a mild course of acute COVID-19 in most of the cases. However, a few non-controlled studies on children present an evaluation of long-term recovery from SARS-CoV-2 infection. Mostly, the studies were conducted on a small sample size with children aged between 0-17 years.
The study aimed to evaluate symptoms and duration of 'long COVID' in children.
Data collection was done through a nationwide cohort study with 37,522 RT-PCR verified SARS-CoV-2 infected children, aged between 0-17 years (response rate 44.9%). Further, the study also had a group of 78,037 children as control (response rate 21.3%). An electronic questionnaire was used to collect data.
It was obtained that symptoms lasting > 4 weeks were common among both SARS-CoV-2 children and controls. However, SARS-CoV-2 infected children with the age of 6-17 years reported symptoms more frequently than the control group (percent difference 0.8%).
The most reported symptoms among pre-school children were
Fatigue Risk Difference (RD) 0.05 (CI 0.04-0.06)
Loss of smell RD 0.01 (CI 0.01-0.01)
Loss of taste RD 0.01 (CI 0.01-0.02)
Muscle weakness RD 0.01 (CI 0.00-0.01)
However, in school children, respiratory problems RD 0.03 (CI 0.03-0.04), dizziness RD 0.02 (CI 0.02-0.03), chest pain RD 0.01 (CI 0.01-0.01) were also observed along with the above-mentioned symptoms.
Furthermore, children in the control group experienced significantly more concentration difficulties, headache, muscle and joint pain, cough, nausea, diarrhea and fever than SARS-CoV-2 infected.
In most of the cases, 'long COVID' symptoms resolve in children within 1-5 months. Therefore, it can be interpreted that long COVID in children is rare and mainly of short duration.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
In heavily pretreated DLBCL, Triplet Scores a Survival Victory.
2.
Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer
3.
No Survival Bump in Metastatic NSCLC With Addition of ADC to Immunotherapy
4.
Drop in credit score after cancer diagnosis linked to increased mortality
5.
What is a "cancer vaccine" and is it the same as a COVID vaccine?
1.
The Risk Factors of Venous Thromboembolism and How to Lower Your Chances
2.
Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study
3.
Environmental Carcinogen Avoidance in Precision Prevention
4.
Digital Oncology Command Platforms for Longitudinal Cancer Care Coordination
5.
Clinical Trends in Oncology in Clinical Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
Early Warning Signs of Cancer
4.
Recognizing Symptoms That May Require Cancer Evaluation
5.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation